1-(2-pyridylmethyl)-1H-indazol-3-ol | 1245742-45-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并吡唑类
• 英文名称: 1-(2-pyridylmethyl)-1H-indazol-3-ol
• 英文别名: 1-(pyridin-2-ylmethyl)-2H-indazol-3-one
• CAS: 1245742-45-3
• 化学式: C₁₃H₁₁N₃O
• 分子量: 225.25
• InChiKey: HWTHEPTXBHSZMU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  17
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.08
• 拓扑面积：
  45.2
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  四氟乙烯 、 1-(2-pyridylmethyl)-1H-indazol-3-ol 在 氢化钾 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 4.0h， 以82%的产率得到1-(2-pyridylmethyl)-3-(1,1,2,2-tetrafluoroethoxy)-1H-indazole
  参考文献：
  名称：

  Polyfluoroalkylation and alkenylation of 1-benzyl-1H-indazol-3-ol

  摘要：

  The polyfluoroalkylation and alkenylation of 1-benzyl-1H-indazol-3-ol by halopolyfluoroalkanes and fluorinated olefins has been studied. It was shown that only reactions proceeding with the participation of difluorocarbene lead to a mixture of N- and O-alkylation products. In all other cases, interaction with halopolyfluoroethanes and polyfluoroalkenes forms O-polyfluoroalkyl and alkenyl derivatives of indazolol.

  DOI：

  10.1007/s10593-011-0670-y
• 作为产物：
  描述：

  2-氯甲基吡啶盐酸盐 、 3-羟基-1H-吲唑 在 sodium hydroxide 作用下， 以 水 为溶剂， 以67%的产率得到1-(2-pyridylmethyl)-1H-indazol-3-ol
  参考文献：
  名称：

  Polyfluoroalkylation and alkenylation of 1-benzyl-1H-indazol-3-ol

  摘要：

  The polyfluoroalkylation and alkenylation of 1-benzyl-1H-indazol-3-ol by halopolyfluoroalkanes and fluorinated olefins has been studied. It was shown that only reactions proceeding with the participation of difluorocarbene lead to a mixture of N- and O-alkylation products. In all other cases, interaction with halopolyfluoroethanes and polyfluoroalkenes forms O-polyfluoroalkyl and alkenyl derivatives of indazolol.

  DOI：

  10.1007/s10593-011-0670-y

文献信息

• Methods and compositions of treating a flaviviridae family viral infection
  申请人：Einav Shirit

  公开号：US20100015093A1

  公开（公告）日：2010-01-21

  Briefly described, embodiments of this disclosure include compounds, pharmaceutical compositions, methods of treating a host infected with a virus from the Flaviviridae family of viruses, methods of inhibiting HCV replication in a host, methods of inhibiting the binding of NS4B polypeptide to the 3′UTR of HCV negative strand RNA in a host, methods of treating liver fibrosis in a host, and the like.

  简要概述，本公开的实施例包括化合物、药物组合物、治疗感染黄病毒科病毒的宿主的方法、抑制宿主中HCV复制的方法、抑制NS4B多肽与HCV负链RNA的3′UTR结合的方法、治疗宿主肝纤维化的方法等。
• METHODS AND COMPOSITIONS OF TREATING A FLAVIVIRIDAE FAMILY VIRAL INFECTION
  申请人：Glenn Jeffrey S.

  公开号：US20120148534A1

  公开（公告）日：2012-06-14

  Briefly described, embodiments of this disclosure include compounds, pharmaceutical compositions, methods of treating a host infected with a virus from the Flaviviridae family of viruses, methods of inhibiting HCV replication in a host, methods of inhibiting the binding of NS4B polypeptide to the 3′UTR of HCV negative strand RNA in a host, methods of treating liver fibrosis in a host, and the like.

  简单地说，本公开的实施例包括化合物、药物组合物、治疗感染黄病毒科病毒的宿主的方法、抑制宿主中HCV复制的方法、抑制NS4B多肽与HCV负链RNA的3'UTR结合的方法、治疗宿主肝纤维化的方法等。
• US8940730B2
  申请人：——

  公开号：US8940730B2

  公开（公告）日：2015-01-27
• US9149463B2
  申请人：——

  公开号：US9149463B2

  公开（公告）日：2015-10-06
• [EN] METHODS AND COMPOSITIONS OF TREATING A FLAVIVIRIDAE FAMILY VIRAL INFECTION<br/>[FR] MÉTHODES ET COMPOSITIONS POUR TRAITER L'INFECTION PAR UN VIRUS DE LA FAMILLE DES FLAVIVIRIDAE
  申请人：UNIV LELAND STANFORD JUNIOR

  公开号：WO2010107742A2

  公开（公告）日：2010-09-23

  Briefly described, embodiments of this disclosure include compounds, pharmaceutical compositions, methods of treating a host infected with a virus from the Flaviviridae family of viruses, methods of inhibiting HCV replication in a host, methods of inhibiting the binding of NS4B polypeptide to the 3'UTR of HCV negative strand RNA in a host, methods of treating liver fibrosis in a host, and the like.